Atividade física de vida diária, capacidade de exercício e qualidade de vida de pacientes com doença de Crohn em remissão infliximab-induzida
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Background: Physical activity in daily life and exercise capacity have never been assessed in Crohn’s disease (CD) patients on infliximab-induced remission.
Objective: We aimed to evaluate the physical activity in daily life, exercise capacity, quality of life (QoL) and mood disorders in patients with moderate-to-severe CD on infliximab-induced remission, and to investigate variables associated with physical activity in daily life in these patients.
Methods: A cross-sectional study was conducted, in which 26 patients with CD were selected. Controls were currently asymptomatic individuals with functional dyspepsia. Patients underwent to evaluation of physical activity in daily life by a triaxial accelerometer, exercise capacity (shuttle walk test-SWT), handgrip strength, QoL and mood disorders. The associations between the physical activity in daily life and QoL or mood disorders were tested.
Results: The number of steps taken (7446 ± 3081 vs. 7898 ± 2487), the active time (80.56 ± 41.97 min vs. 89.65 ± 24.30 min), the SWT distance (662.69 ± 252.86 m vs. 728.82 ± 346.55 m) and the handgrip (34.3 ± 11.1 kgf vs. 32.9 ± 11.9 kgf) didn’t show significant difference between CD patients and controls, respectively. The time spending lying down (116.31 ± 107.38 min vs. 63.71 ± 55.79 min) and some domains of quality of life were superior in CD patients (p< 0.05). No correlation was observed between the level of physical activity in daily life and QoL or mood disorders in CD patients (p>0.05).
Conclusions: We found that patients with CD on infliximab-induced remission have the same level of physical activity in daily life and exercise capacity when compared with controls.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
